Most Recent
Momofuku restaurant loses challenge to instant Ramen maker’s trade mark
Famed restaurant chain Momofuku has lost its challenge to the ‘Momofuku’ word mark of instant noodle giant Nissin, with IP Australia finding consumers were not likely to be deceived or confused because of the different goods and services provided by the two companies.
Fonterra to appeal ruling over Bega trade mark licences
Dairy company Fonterra is reportedly challenging a court's refusal to give it certainty over lucrative licence agreements with Bega Cheese as it pursues a sale of its Australian business.
Amgen wants Sandoz to give up info on regulatory approval for generic Prolia, Xgeva
Biopharmaceutical company Amgen has lodged proceedings against generic maker Sandoz, calling for documents related to regulatory approval of a generic version of its top-selling bone disease treatments.
Vehicle Management Systems wins extension to renew patents after forgetting to pay fees
A company that manufactures vehicle sensing technology used to monitor public parking has been allowed more time to renew its patents, despite opposition from rival SARB.
Foxtel wins security in $12M dispute over download patent
The owner of a patent for software allowing users to download live television that is suing Foxtel for $12 million has been ordered to cough up $260,000 in security.
Fonterra can’t get pre-deal ruling on sale’s impact on lucrative Bega licences
Dairy company Fonterra can't get a court declaration that its Australian exit plans will not trigger change of control clauses in lucrative licence agreements with Bega, potentially affecting the likely sale price.
Tesla CEO Robyn Denholm loses bid to register ‘Wollemi’ trade mark
CBA-backed climate venture capital firm Wollemi has won its bid to block the family company of Tesla CEO Robyn Denholm from registering ‘Wollemi Capital Group’ as a trade mark.
Sanofi loses challenge to Amgen patents for cholesterol-busting Repatha
Drug giant Sanofi has failed in its appeal of a decision granting applications by biopharmaceutical company Amgen for patents covering the cholesterol-lowering treatment Repatha.
Sky News loses appeal in case of ‘wholesale copying’ by media monitor Isentia
An appeals court has dismissed Sky News' challenge to a ruling that media monitor Isentia was not liable for copyright infringement despite "wholesale copying" of content for government clients.
High Court to hear designer’s trade mark fight with Katy Perry
The High Court has agreed to hear an Australian fashion designer's appeal in a long-running trade mark dispute with pop star Katy Perry.